Trials / Sponsors / Grupo de Estudos Multicentricos em Onco-Hematologia

Grupo de Estudos Multicentricos em Onco-Hematologia

Network · 7 registered clinical trials.

Status	Trial	Phase	Started
Unknown	Daratumumab Intensified Treatment to Eligible MM New Patients CTD-Dara Induction, Follow by Dara Consolidation Multiple Myeloma Stage I	Phase 3	2018-11-20
Unknown	T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients T-cell Lymphoma, NK-Cell Lymphoma, T-cell Lymphoma Adults	—	2015-01-01
Unknown	Randomized Clinical Trial With Aminocaproic Acid in the Prevention of Exodontic Bleeding in Anticoagulants Pat Oral Hemorrhage	Phase 4	2013-12-01
Completed	Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation Multiple Myeloma, Effects of Chemotherapy	Phase 3	2009-06-15
Completed	Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus Graft vs Host Disease, Oral Manifestations	Phase 3	2008-08-01
Unknown	Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Multiple Myeloma	Phase 3	2007-01-01
Completed	Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma Multiple Myeloma	Phase 3	2003-10-01